Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes

Ali T. Taher, John B. Porter, Antonis Kattamis, Vip Viprakasit, M. D. Cappellini

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)4073-4078
Number of pages6
JournalDrug Design, Development and Therapy
Publication statusPublished - Dec 15 2016

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery

Cite this